Google DeepMind has unveiled an artificial intelligence (AI) invention, AlphaGenome, which its developers claim could have a "transformative impact" on medicine discovery by predicting how DNA mutations behave. The technology also holds promise for identifying genes linked to specific conditions and uncovering the causes of rare diseases.
Since its launch last June, thousands of researchers globally have utilised AlphaGenome to aid studies into "neurodegenerative diseases, infectious diseases and cancer." The model functions by predicting how variants or mutations within DNA influence a range of biological processes that regulate genes.
